Discovery of novel A2AR antagonists through deep learning-based virtual screening
Author:
Funder
National Natural Science Foundation of China
Guangzhou Municipal Science and Technology Bureau
Basic and Applied Basic Research Foundation of Guangdong Province
Publisher
Elsevier BV
Subject
General Medicine
Reference31 articles.
1. Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance;Bagchi;Annu Rev Pathol,2021
2. Adenosine signaling and the immune system: when a lot could be too much;Antonioli;Immunol Lett,2019
3. The adenosine pathway in immuno-oncology;Allard;Nat Rev Clin Oncol,2020
4. Immunoregulatory activity of adenosine and its role in human cancer progression;Muller-Haegele;Expert Rev Clin Immunol,2014
5. Structurally enabled discovery of adenosine A(2A) receptor antagonists;Jazayeri;Chem Rev,2017
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Structure-based virtual screening of vast chemical space as a starting point for drug discovery;Current Opinion in Structural Biology;2024-08
2. Integrating artificial intelligence into the modernization of traditional Chinese medicine industry: a review;Frontiers in Pharmacology;2024-02-23
3. Applying molecular docking to pesticides;Pest Management Science;2023-09-11
4. Keeping pace with the explosive growth of chemical libraries with structure‐based virtual screening;WIREs Computational Molecular Science;2023-06-20
5. In Silico Insights Toward the Exploration of Adenosine Receptors Ligand Recognition;Topics in Medicinal Chemistry;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3